Andhra Pradesh - Hyderabad   

Lonza to invest in Genome Valley

HYDERABAD: Switzerland-headquartered Lonza AG, a global biopharma company, will invest Rs.250 crore in a phased manner in its project at the Genome Valley here.

This was indicated by its CEO Stefan Borgas in his key-note address at the Pharma CEOs conclave which concluded here on Friday.

Principal Secretary, Industries, B. P. Acharya, said in a press release later that the ground-breaking for the project is planned to be held during Bio Asia 2011 to be held from February 21. Land for the project was allotted by APIIC in June last year in the Biotech Park, phase-II.

Chief Minister K. Rosaiah, who gave away the export awards of Pharmaexcil, complimented Mr. Borgas for his decision to invest in Genome Valley.

He announced that a new cluster called ‘Medtech Valley' is coming up at Jawaharnagar near Genome Valley for medical devices and equipment manufacturing industries.

Mr. Rosaiah presented 12 Outstanding Export Performance Awards. Ranbaxy Laboraories Limited, Cadila Healthcare, Aurobindo Pharma and Matrix Laboratories were among the companies which bagged Awards.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

CIS countries invite Indian trade and industry
Criminal proceedings against Balaji Fertilizers stayed
Advance I-T payments up by 19.5 %
Plea to postpone Satyam trial rejected
KCR main hurdle for Telangana: TDP
Lonza to invest in Genome Valley
State promises to set right pay anomalies
Balamurali Krishna's concert tomorrow
Grant for MSME units
Red Cross awards for DRO
A lucid biography
Asher Noria felicitated by his alma mater
Police arrest Divya's “killer”
Fire in two shops
L.B.Nagar-Kukatpally road to be widened
Viva for distance education MBA candidates
Himayathsagar to the brim
Cases against students may be lifted
Water to city: Japan aid for Godavari scheme
No water problem in city till June 2012: Minister
Call for united approach to combat terrorism
In Hyderabad Today

Copyright © 2010, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu